238 related articles for article (PubMed ID: 17341619)
1. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
Min G
Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
[TBL] [Abstract][Full Text] [Related]
2. Effects of TK promotor and hepatocyte nuclear factor-4 in CAR-mediated transcriptional activity of phenobarbital responsive unit of CYP2B gene in monkey kidney epithelial-derived cell line COS-7.
Min G
Ann N Y Acad Sci; 2006 Dec; 1091():258-69. PubMed ID: 17341620
[TBL] [Abstract][Full Text] [Related]
3. Estrogen modulates transactivations of SXR-mediated liver X receptor response element and CAR-mediated phenobarbital response element in HepG2 cells.
Min G
Exp Mol Med; 2010 Nov; 42(11):731-8. PubMed ID: 20871212
[TBL] [Abstract][Full Text] [Related]
4. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ
Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
Ni YD; Hong WJ; Zhou YC; Grossmann R; Zhao RQ
Steroids; 2010 Mar; 75(3):245-51. PubMed ID: 20043933
[TBL] [Abstract][Full Text] [Related]
6. Novel mammalian cell lines expressing reporter genes for the detection of environmental chemicals activating endogenous aryl hydrocarbon receptors (ArhR) or estrogen receptors (ER).
Minh SD; Below S; Müller C; Hildebrandt JP
Toxicol In Vitro; 2008 Dec; 22(8):1935-47. PubMed ID: 18835349
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators.
Min G; Kim H; Bae Y; Petz L; Kemper JK
J Biol Chem; 2002 Sep; 277(37):34626-33. PubMed ID: 12114525
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of estrogen receptor signaling by gamma synuclein.
Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
[TBL] [Abstract][Full Text] [Related]
9. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
11. A stable fish reporter cell line to study estrogen receptor transactivation by environmental (xeno)estrogens.
Cosnefroy A; Brion F; Guillet B; Laville N; Porcher JM; Balaguer P; Aït-Aïssa S
Toxicol In Vitro; 2009 Dec; 23(8):1450-4. PubMed ID: 19591918
[TBL] [Abstract][Full Text] [Related]
12. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
13. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2).
Paumi CM; Smitherman PK; Townsend AJ; Morrow CS
Biochemistry; 2004 Mar; 43(8):2345-52. PubMed ID: 14979731
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
Koohi MK; Ivell R; Walther N
J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
[TBL] [Abstract][Full Text] [Related]
17. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
Liu J; Sidell N
Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415
[TBL] [Abstract][Full Text] [Related]
18. Anatomy of the estrogen response element.
Gruber CJ; Gruber DM; Gruber IM; Wieser F; Huber JC
Trends Endocrinol Metab; 2004 Mar; 15(2):73-8. PubMed ID: 15036253
[TBL] [Abstract][Full Text] [Related]
19. Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma.
Huppunen J; Wohlfahrt G; Aarnisalo P
Mol Cell Endocrinol; 2004 Apr; 219(1-2):151-60. PubMed ID: 15149736
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
